【摘要】 目的对依达拉奉联合尼莫地平治疗急性脑梗死的临床疗效进行观察和分析。方法选取我科收治的80例急性脑梗死患者为例,随机分组,对照组和实验组各40例。对照组患者采用常规方法进行治疗,实验组患者在对照组常规治疗的基础上增加依达拉奉联合尼莫地平进行治疗,观察和比较两组患者的临床疗效。结果实验组患者的总有效率为95%,对照组患者的总有效率为62.5%,实验组患者的总有效率相比对照组更高,差异明显,有统计学意义,P<0.05;治疗前实验组和对照组的NIHSS分值分别为(23.42±10.21)分和(22.22±9.87)分,治疗后实验组和对照组的NIHSS分值分别为(5.33±1.23)分和(15.21±8.09)分,神经功能缺损改善程度相比对照组更大,差异明显,有统计学意义,P<0.05。两组患者均无严重不良反应患者。结论采用依达拉奉联合尼莫地平对急性脑梗死进行治疗,效果明显,值得推广和普及。更多还原

【Abstract】 Objective: to in accordance with the joint edaravone in nim horizon in treatment of acute cerebral infarction clinical curative effect of observation and analysis. Methods: select our hospital 80 cases of patients with acute cerebral infarction, for example, a randomized, control group and experimental group 40 cases each. In the control group were treated by conventional methods for treatment, the experimental group patients in the control group conventional treatment on the basis of the increase in joint edaravone in nim horizon treatment, observe and compare the clinical efficacy of two groups of patients. Results: the total effective rate was 95% in patients with the control group total effective rate of the patients was 62.5%, higher than the total effective rate of experimental group patients, the difference is apparent, was statistically significant, P<0.05; NIHSS score of experimental group and the control group before treatment were(23.42±10.21) and(22.22±9.87) points, NIHSS score of experimental group and the control group after treatment respectively(5.33±1.23) and(15.21±8.09) points, larger than the degree of nerve function defect improvement, obvious differences, there is statistical significance,(P<0.05). Patients with two groups of patients had no serious adverse reactions. Conclusion: the edaravone in joint nim to treatment of acute cerebral infarction, obvious effect, worthy of promotion and popularization.更多还原